Concepedia

M Berti

MB

29

Publications

1.3K

Citations

20

H-Index

1973

Active since

Affiliations

Gruppo CLAS (Italy)(Current)

Fondazione Audiologica Varese

Tumour Institute of Tuscany

Newron Pharmaceuticals (Italy)

M Berti is an author at Gruppo CLAS (Italy) specializing in medicine, drug resistance, and pharmacology.

Top concepts

Publications per year

1973–2000

29

Publications

29

Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties.

Francesca Parenti, G. BERETTA, M Berti et al. · The Journal of Antibiotics · 1978 · 216 citations · Full text

Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. I. Isolation and characterization.

Enrico Selva, G. BERETTA, Nicoletta Montanini et al. · The Journal of Antibiotics · 1991 · 182 citations · Full text

A40926, a new glycopeptide antibiotic with anti-Neisseria activity

Beth P. Goldstein, Enrico Selva, Luciano Gastaldo et al. · Antimicrobial Agents and Chemotherapy · 1987 · 118 citations · Full text

, , +15

Teichomycin: <i>in-vitro</i> and <i>in-vivo</i> evaluation in comparison with other antibiotics

R Pallanza, M Berti, Beth P. Goldstein et al. · Journal of Antimicrobial Chemotherapy · 1983 · 87 citations

, , +19

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products.

Adriano Malabarba, Paolo Strazzolini, A. Depaoli et al. · The Journal of Antibiotics · 1984 · 83 citations · Full text

Rows per page

1–5 of 29